2026. Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s728. DOI:https://doi.org/10.25251/wx06pe13.